Trial Outcomes & Findings for Simplified Negative Pressure Wound Therapy (NCT NCT01339429)

NCT ID: NCT01339429

Last Updated: 2015-05-20

Results Overview

The negative pressure being delivered by the device was measured on a daily basis for three days. Maintenance of negative pressure was defined as negative pressure delivery within 75% of the starting negative pressure amount.

Recruitment status

COMPLETED

Study phase

PHASE1

Target enrollment

41 participants

Primary outcome timeframe

3 days

Results posted on

2015-05-20

Participant Flow

Hospital wards were surveyed daily over the study period for eligible patients. Photographs of wounds ranging from 2-150 cm2 in size and clinical histories were reviewed for study enrollment eligibility criteria.

47 patients consented. 6 did not meet inclusion criteria. 1 voluntarily withdrew. 4 not enrolled due to clinical changes.

Participant milestones

Participant milestones
Measure
Simplified Negative Pressure Wound Therapy
The simplified negative pressure wound therapy device was placed on subjects selected from hospital wards and meeting the eligibility criteria regarding wound size and condition. Inclusion criteria included age 14 years or older, adequate adjacent intact skin and wound location for application of the sNPWT dressing, adequate pain control, and anticipated clinically stability and hospitalization for the duration of the study. Exclusion criteria were exposed blood vessels, evidence of ischemia, necrotic tissue requiring further debridement, infection, osteomyelitis, and malignancy in the wound. Simplified negative pressure wound therapy device: A non-powered negative pressure wound therapy device utilizing a bellows connected to a specialized dressing via a drainage tube.
Overall Study
STARTED
41
Overall Study
COMPLETED
37
Overall Study
NOT COMPLETED
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Simplified Negative Pressure Wound Therapy
The simplified negative pressure wound therapy device was placed on subjects selected from hospital wards and meeting the eligibility criteria regarding wound size and condition. Inclusion criteria included age 14 years or older, adequate adjacent intact skin and wound location for application of the sNPWT dressing, adequate pain control, and anticipated clinically stability and hospitalization for the duration of the study. Exclusion criteria were exposed blood vessels, evidence of ischemia, necrotic tissue requiring further debridement, infection, osteomyelitis, and malignancy in the wound. Simplified negative pressure wound therapy device: A non-powered negative pressure wound therapy device utilizing a bellows connected to a specialized dressing via a drainage tube.
Overall Study
Withdrawal by Subject
1
Overall Study
Physician Decision
3

Baseline Characteristics

Simplified Negative Pressure Wound Therapy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Simplified Negative Pressure Wound Therapy
n=41 Participants
The simplified Negative Pressure device will be placed on subjects selected from the hospital wards and meeting the eligibility criteria. simplified Negative Pressure device: A non-powered negative pressure device utilizing a bellows which is compressed every eight hours.
Age, Customized
14 to 90 Years
41 participants
n=5 Participants
Sex/Gender, Customized
Male
2 participants
n=5 Participants
Sex/Gender, Customized
Female
2 participants
n=5 Participants
Sex/Gender, Customized
Unknown
37 participants
n=5 Participants
Region of Enrollment
Rwanda
41 participants
n=5 Participants

PRIMARY outcome

Timeframe: 3 days

Population: 85 dressings were applied. 5 applications excluded due to a change in patient condition, unrelated to sNPWT. 9 dressings excluded due to occlusion of the drainage tube. 71 dressings were analyzed in total.

The negative pressure being delivered by the device was measured on a daily basis for three days. Maintenance of negative pressure was defined as negative pressure delivery within 75% of the starting negative pressure amount.

Outcome measures

Outcome measures
Measure
Simplified Negative Pressure Wound Therapy
n=71 dressings
The simplified negative pressure wound therapy device will be placed on subjects selected from the surgical ward and meeting the eligibility criteria regarding wound size and condition. Simplified negative pressure wound therapy device: A non-powered negative pressure wound therapy device utilizing a bellows connected to a specialized dressing.
Maintenance of Negative Pressure
22.2 hours
Standard Deviation 27.0

SECONDARY outcome

Timeframe: 3 days

Any adverse events, including bleeding, wound complication, or change in patient condition during the trial period will be recorded.

Outcome measures

Outcome measures
Measure
Simplified Negative Pressure Wound Therapy
n=71 dressings
The simplified negative pressure wound therapy device will be placed on subjects selected from the surgical ward and meeting the eligibility criteria regarding wound size and condition. Simplified negative pressure wound therapy device: A non-powered negative pressure wound therapy device utilizing a bellows connected to a specialized dressing.
Number of Participants With Serious Adverse Events
0 participants

Adverse Events

Simplified Negative Pressure Wound Therapy

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Simplified Negative Pressure Wound Therapy
n=41 participants at risk
The simplified negative pressure wound therapy device was placed on subjects selected from the hospital wards and meeting the eligibility criteria regarding wound size and condition. Simplified negative pressure wound therapy device: A non-powered negative pressure wound therapy device utilizing a bellows connected to a specialized dressing.
Immune system disorders
Fever
2.4%
1/41 • Number of events 1

Additional Information

Dr. Gita Mody

Brigham and Women's Hospital

Phone: 617-921-8221

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place